Page last updated: 2024-12-06

bikaverin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Bikaverin is a red pigment produced by the fungus Fusarium moniliforme. It exhibits a variety of biological activities, including antifungal, antibacterial, and cytotoxic effects. Bikaverin is known to inhibit the growth of various pathogenic fungi, including Candida albicans and Aspergillus fumigatus. It also shows activity against some bacteria, including Staphylococcus aureus and Escherichia coli. Bikaverin has attracted attention for its potential as an anticancer agent. Studies have shown that it can induce apoptosis (programmed cell death) in cancer cells and inhibit their proliferation. Bikaverin's mechanism of action involves interfering with the production of certain proteins crucial for cell growth and survival. Further research is needed to fully understand its therapeutic potential.'

bikaverin : A organic heterotetracyclic compound that is 10H-benzo[b]xanthene-7,10,12-trione substituted by hydroxy groups at positions 6 and 11, methoxy groups at positions 3 and 8 and a methyl group at position 1. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID36433
CHEMBL ID373432
CHEBI ID3096
MeSH IDM0040347

Synonyms (31)

Synonym
NSC215139 ,
lycopersin
10h-benzo[b]xanthene-7,12-trione, 6,11-dihydroxy-3,8-dimethoxy-1-methyl-
nsc-215139
NCI60_001795
10h-benzo(b)xanthene-7,10,12-trione, 6,11-dihydroxy-3,8-dimethoxy-1-methyl-
brn 0358013
7,10-dihydro-6,11-dihydroxy-3,8-dimethoxy-1-methyl-12h-benzo(b)xanthene-7,10,12-trione
6,11-dihydroxy-3,8-dimethoxy-1-methyl-10h-benzo(b)xanthene-7,10,12-trione
nsc 215139
NEURO_000112
33390-21-5
bikaverin
chebi:3096 ,
CHEMBL373432
5-18-05-00692 (beilstein handbook reference)
f1n6bx58pj ,
unii-f1n6bx58pj
6,11-dihydroxy-3,8-dimethoxy-1-methyl-10h-benzo[b]xanthene-7,10,12-trione
HB3801
ZOQMSOSJEWBMHP-UHFFFAOYSA-N
6,11-dihydroxy-3,8-dimethoxy-1-methyl-benzo[b]xanthene-7,10,12-trione
DTXSID80187020
J-019172
Q27105942
HY-121004
CS-0078923
6,11-dihydroxy-3,8-dimethoxy-1-methyl-7h-benzo[b]xanthene-7,10,12-trione
7,10-dihydroxy-3,8-dimethoxy-1-methylbenzo[b]xanthene-6,11,12-trione
GLXC-15007
AKOS040747975

Research Excerpts

Overview

Bikaverin is a reddish pigment produced by different fungal species, most of them from the genus Fusarium. It has antibiotic properties against certain protozoa and fungi.

ExcerptReferenceRelevance
"Bikaverin is a red metabolite present mainly in species of the genus Fusarium."( Natural blue pigments and bikaverin.
Bicas, JL; Santos, MCD, 2021
)
1.64
"Bikaverin is a polyketide having antitumor and antibiotic potential."( siRNA mediated gene silencing in Fusarium sp. HKF15 for overproduction of bikaverin.
Deshmukh, R; Purohit, HJ, 2014
)
1.35
"Bikaverin is a reddish pigment produced by different fungal species, most of them from the genus Fusarium, with antibiotic properties against certain protozoa and fungi. "( Bikaverin production and applications.
Avalos, J; Limón, MC; Rodríguez-Ortiz, R, 2010
)
3.25
"Bikaverin is a polyketide-derived pigment produced by multiple species of the fungus Fusarium, some of which can cause ear and kernel rot of maize. "( LC-MS/MS method for the determination of the fungal pigment bikaverin in maize kernels as an indicator of ear rot.
Busman, M; Butchko, RA; Proctor, RH, 2012
)
2.06

Treatment

Bikaverin pretreatment potentiated the H2O2-induced neuronal markers, such as BDNF, TH, and AADC expression. Treatment with bikaversin at 300 microg ml(-1) suppressed the development of tomato late blight by 71%.

ExcerptReferenceRelevance
"Bikaverin pretreatment efficiently potentiated the H2O2-induced neuronal markers, such as BDNF, TH, and AADC expression, which orchestrate the neuronal damage of the cell."( Neuroprotective effects of bikaverin on H2O2-induced oxidative stress mediated neuronal damage in SH-SY5Y cell line.
Chandranayaka, S; Jameel, NM; Nirmaladevi, D; Ramesha, A; Srinivas, C; Venkataramana, M, 2014
)
1.42
"Treatment with bikaverin at 300 microg ml(-1) suppressed the development of tomato late blight by 71%."( Bikaverin and fusaric acid from Fusarium oxysporum show antioomycete activity against Phytophthora infestans.
Choi, GJ; Jang, KS; Kim, HY; Kim, JC; Lee, S; Lee, SO; Lim, HK; Son, SW; Sung, ND, 2008
)
2.13
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID277810Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay2007Journal of natural products, Feb, Volume: 70, Issue:2
Search for cell motility and angiogenesis inhibitors with potential anticancer activity: beauvericin and other constituents of two endophytic strains of Fusarium oxysporum.
AID277808Cytotoxicity against human NCI-H460 cells after 72 hrs by MTT assay2007Journal of natural products, Feb, Volume: 70, Issue:2
Search for cell motility and angiogenesis inhibitors with potential anticancer activity: beauvericin and other constituents of two endophytic strains of Fusarium oxysporum.
AID277809Cytotoxicity against human MIAPaCa2 cells after 72 hrs by MTT assay2007Journal of natural products, Feb, Volume: 70, Issue:2
Search for cell motility and angiogenesis inhibitors with potential anticancer activity: beauvericin and other constituents of two endophytic strains of Fusarium oxysporum.
AID277811Cytotoxicity against human SF268 cells after 72 hrs by MTT assay2007Journal of natural products, Feb, Volume: 70, Issue:2
Search for cell motility and angiogenesis inhibitors with potential anticancer activity: beauvericin and other constituents of two endophytic strains of Fusarium oxysporum.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (38)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (5.26)18.7374
1990's3 (7.89)18.2507
2000's8 (21.05)29.6817
2010's19 (50.00)24.3611
2020's6 (15.79)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 29.69

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index29.69 (24.57)
Research Supply Index3.76 (2.92)
Research Growth Index5.09 (4.65)
Search Engine Demand Index36.71 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (29.69)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (7.14%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other39 (92.86%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]